Antibiotic drugs are the basis of urinary tract infection treatment. Antibiotic treatment involves determining the type of bacteria present and choosing the appropriate drug. Antibacterials for urine infections include nalidixic acid, nitrofurantoin, ofloxacin and norfloxacin (for complicated urinary tract infections).

The global Treatment for Genito-Urinary market was valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025.
This report focuses on Treatment for Genito-Urinary volume and value at global level, regional level and company level. From a global perspective, this report represents overall Treatment for Genito-Urinary market size by analyzing historical data and future prospect.
Regionally, this report categorizes the production, apparent consumption, export and import of Treatment for Genito-Urinary in North America, Europe, China, Japan, Southeast Asia and India.
For each manufacturer covered, this report analyzes their Treatment for Genito-Urinary manufacturing sites, capacity, production, ex-factory price, revenue and market share in global market.

The following manufacturers are covered:
Daiichi Sankyo Company
Pfizer
Bayer
Astellas Pharma
Allergan
GSK
Otsuka Pharmaceutical
Sanofi

Segment by Regions
North America
Europe
China
Japan
Southeast Asia
India

Segment by Type
OTC
Rx Drugs

Segment by Application
Hospital
Drugs Store
Other